Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06686329
NA

Physical Activity to Prevent and Treat Hyperglycemia From a Mistimed Bolus Insulin Dose

Sponsor: Jane Yardley

View on ClinicalTrials.gov

Summary

People living with type 1 diabetes (PwT1D) are recommended to administer insulin 10-15 minutes before meal consumption (pre-bolus), to account for the delay in the glucose lowering action associated with subcutaneously administered insulin. Due to the demands of day-to-day life, pre-bolusing is not always possible or may be forgotten. With continuous glucose monitors (CGMs), PwT1D may be alerted to this missed insulin dose by a CGM alert, including rapidly rising glucose (change \>2.5mmol/L/15min) or hyperglycemia (\>10.0 mmol/L), and deliver a mistimed (post-prandial) dose in response to CGM alert. This study was designed to determine the effect of combining a post-prandial/mistimed insulin dose with 15 minutes of brisk walking. It is expected that walking will help to minimize or prevent hyperglycemia after a mistimed bolus insulin dose, as well as blunt the rise in glucose following a mistimed insulin dose.

Official title: Physical Activity to Prevent and Treat Hyperglycemia From a Mistimed Bolus Insulin Dose: The MISSED DOSE Study

Key Details

Gender

All

Age Range

18 Years - 24 Years

Study Type

INTERVENTIONAL

Enrollment

30

Start Date

2025-03-17

Completion Date

2026-09-30

Last Updated

2026-03-12

Healthy Volunteers

No

Interventions

BEHAVIORAL

Control (CON)

Standardized meal with insulin administered 15 minutes before eating

BEHAVIORAL

Missed Dose (MISS)

Standardized meal with insulin administered post-prandially when alerted to rapidly rising glucose (increase of 0.2 mmol/L/min) or hyperglycemia (\> 10.0 mmol/L) by CGM

BEHAVIORAL

Missed Dose + 15min walk (MISS+EX)

Standardized meal with insulin administered post-prandially when alerted to rapidly rising glucose (increase of 0.2 mmol/L/min) or hyperglycemia (\> 10.0 mmol/L) by CGM with a 15-minute walk performed immediately after insulin administration

Locations (1)

Institut de recherches cliniques de Montréal

Montreal, Quebec, Canada